ClinicalTrials.gg
CompletedNCT06259734Updated Apr 30, 2026

Transfusion Camp for Medical Students in Rwanda

An interventional study of Transfusion Camp Rwanda education in Global Health and Medical Education, sponsored by University of British Columbia. Completed at 1 site in Rwanda. Per ClinicalTrials.gov, last updated 2026-04-30.

Sponsored by University of British Columbia · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
145
Allocation
Non-randomized
Sex
All
01

Study summary

Transfusion medicine is closely linked with safe surgery. Transfusion Camp is a multidisciplinary educational project aimed at improving transfusion medicine knowledge in physicians. The course has been piloted in Rwanda, showing improvement in participant knowledge and confidence, resulting in its recommended implementation into the medical school curriculum.

This project aims to evaluate a multi-day Transfusion Camp course mandatory for graduating medical students and first-year interns practicing in district hospitals in Rwanda. Its implementation is evaluated through pre- and post-course testing, collecting participants' blood ordering practices following the course, and conducting participant interviews about barriers to safe transfusion medicine in their hospital.

Read the detailed description

Purpose: to assess efficacy of the recommendation set out through the University of Rwanda faculty working group discussions and the Canada-Rwanda Transfusion Camp partnership to implement a mandatory, annual multi-day Transfusion Camp course for final year medical students preparing to enter internship training and dispersing across the majority of district hospitals in Rwanda.

Hypothesis: (1) Graduating medical students and new interns will have a statistically significant improvement in their test scores after a 3-day Transfusion Camp Rwanda course. (2) There will be a statistically significant positive change in blood product ordering practices among course participants when compared with interns who have not participated in Transfusion Camp Rwanda. (3) In conducting semi-structured interviews of participants who took part in Transfusion Camp Rwanda the investigators will identify key enablers and barriers that are faced by participants in patient blood management that will give insight on strategies for future research and interventions.

Population: Final year graduating University of Rwanda medical students about to enter their internship year at district hospitals in Rwanda and new interns currently in the first year of their internship at district hospitals in Rwanda.

Research method:

  1. Knowledge assessment and course evaluation: A validated pre-test assessment used currently in Transfusion Camp Rwanda will be administered prior to and after the session is complete. This test is a regular component of all Transfusion Camp courses in Canada, the United Kingdom, and Rwanda and separate from the research component of this project. It is a portion of the standard Transfusion Camp curriculum.This assessment is a combination of knowledge-based multiple-choice questions, questions on confidence in carrying out transfusion medicine decision-making in patient care, and a brief course evaluation to inform future courses. After 3 months, a second post-test assessment will be administered in the same manner as the pre- and post-test to assess knowledge retention. This test also asks the question about whether or not participants have applied their new knowledge in clinical practice, which will give some insight into the applicability of the course work in Transfusion Camp to real-life transfusion problems in clinical practice in Rwanda.
  2. Blood product ordering practices: blood ordering practices of intern physicians will be collected using the blood product order form currently in use at all laboratories and health centres in Rwanda for the ordering of blood products. Control data will be collected at district hospitals prior to Transfusion Camp: ordering practices of intern physicians at district hospitals who did not participate in Transfusion Camp and, where possible, the hospital does not have faculty who have previously participated in Transfusion Camp. Three months following Transfusion Camp, the blood ordering practices of Transfusion Camp participants will be collected over a three-month period.
  3. Semi-structured interviews: Participants who indicated interest during Transfusion Camp will be contacted to consent to an interview three months post-Transfusion Camp to allow opportunity and time for the participants to apply what has been learned. The interviews aim to gain insight into contextual factors, including hospital culture, hierarchy, product availability, resources for continuing professional development, and anything else that may act as barriers to them being able to follow the Rwanda transfusion guidelines taught and reinforced in Transfusion Camp Rwanda. Interviews will preferably take place face-to-face with two interviewers, a Canadian faculty well experienced in the Transfusion Camp curriculum and one Rwandan faculty member who is also experienced in the curriculum but aware of the cultural context and able to communicate in Kinyarwanda as required.
02

Conditions studied

  • Global Health
  • Medical Education
03

In context

Lead sponsor

University of British Columbia is the lead sponsor of 1,339 studies on the registry; 259 are open to participants now.

Of its 6 completed or terminated interventional studies of FDA-regulated products, 1 (17%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Final year graduating University of Rwanda medical students about to enter their internship year at district hospitals in Rwanda and new interns currently in their first year of their internship at district hospitals in Rwanda.

Exclusion criteria

Exclusion Criteria:

  • N/A
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
145 participants (actual)

Study arms

  • Experimental
    Transfusion Camp Rwanda course participants

    This group will participate in a 3 day course on best practices in Transfusion Medicine in Rwanda. They will participate in testing before and after the course to ascertain knowledge gained. They will then begin to work in hospitals ordering blood for their patients. Data collectors will access their blood product orders and determine the level of appropriateness of their orders based on the Rwanda Biomedical Centre National Transfusion Guidelines.

    Behavioral: Transfusion Camp Rwanda education

  • No intervention
    Intern Physicians not participating in Transfusion Camp

    Blood product ordering practices with be assessed for appropriateness in physicians who did not participate in Transfusion Camp.

Interventions

  • BehavioralTransfusion Camp Rwanda education

    Transfusion Camp Rwanda 3 day education intervention covering all aspects of safe blood transfusion practices as per the Rwanda Biomedical Centre National Transfusion Guidelines

06

What researchers measure

Primary outcomes

  1. Proportion of appropriate transfusion orders

    The proportion of blood product transfusion orders classified as appropriate with 0 being no orders appropriate and 1 being all orders appropriate

    Time frame: 3 months after Transfusion Camp Course

  2. Test score

    Mean change in test scores of course participants

    Time frame: End of 3 day course

  3. Retention test score

    Mean change in test scores of course participants

    Time frame: 3 months after course

07

Study locations

1 site
  • University of Rwanda
    Kigali, Rwanda
08

References and documents

Individual participant data

Plan to share: No — Only study investigators will have access to participant data. There is no plan to share this data beyond study investigators.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from May 2024 to primary completion in Feb 2025, 9 months.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 6, 2024
First posted
Feb 14, 2024
StartActual
May 6, 2024
Primary completionActual
Feb 28, 2025
CompletionActual
Dec 31, 2025
Last update
Apr 30, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 30, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06259734
Collaborators
University of Rwanda
Responsible party
Teresa Skelton (Clinical Assistant Professor, University of British Columbia) — Principal investigator
First posted
Feb 14, 2024
Start date
May 6, 2024
Primary completion
Feb 28, 2025
Completion
Dec 31, 2025
Last update
Apr 30, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion